Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v7-EN
Language English English
Date Updated 2022-01-19 2021-12-14
Drug Identification Number 00022381 00022381
Brand name CORTROSYN INJ 0.25MG CORTROSYN INJ 0.25MG
Common or Proper name Cosyntropin Cosyntropin
Company Name AMPHASTAR PHARMACEUTICALS, INC. AMPHASTAR PHARMACEUTICALS, INC.
Ingredients TETRACOSACTIDE TETRACOSACTIDE
Strength(s) 0.25MG 0.25MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 0.25 mg/vial 0.25 mg/vial
ATC code H01AA H01AA
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-10-25 2021-10-25
Actual start date 2021-10-25 2021-10-25
Estimated end date 2022-01-24 2022-01-05
Actual end date 2022-01-18
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments